W0 2011/000721 A1 I||||||||||||||||||||||||||||||||||||||||||||||||||||||||| - Questel

or methyl substituted 1,3-thiazole; or R 3 is a methyl group (-CH 3 )
substituted with said A group, as a medicament for the treatment and/or
prevention of HIV, Ebola, Dengue, Hepatitis C, SARS or tuberculosis
infections
17. Compound according to claim 12 as a medicament for the treatment
and/or prevention of HIV, Ebola, Dengue, Hepatitis C, SARS or
tuberculosis infections.
18. A pharmaceutical composition comprising a suitable effective amount of
one or more of the compounds according to claims 1 to 12 together
with pharmaceutically acceptable excipients.
19. The pharmaceutical composition according to claims 18, wherein said
excipients and/or additives selected in the group comprising diluent,
solvents, bulking agents, fillers, reological modifier, stabilizers, binders,
lubricants, disintegrant, preservatives, pH adjusting agents, buffers,
antioxidant, chelating agents, plasticizer, polymers, emulsifiers,
edulcorants, flavoring agents, alone or in combination thereof.
20. The pharmaceutical composition of any one of claim 18 or 19 for the
oral, including buccal or sublingual; rectal; nasal; transdermal; vaginal;
or parenteral, including subcutaneous, intramuscular, intravenous or
intradermal or topical administration.